BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21404227)

  • 1. L-Carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tissues.
    Sayed-Ahmed MM
    J Nephrol; 2011; 24(4):490-8. PubMed ID: 21404227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats.
    Al-Shabanah OA; Aleisa AM; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Fatani AG; Sayed-Ahmed MM
    Nephrol Dial Transplant; 2010 Jan; 25(1):69-76. PubMed ID: 19737869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.
    Sayed-Ahmed MM; Darweesh AQ; Fatani AJ
    Oxid Med Cell Longev; 2010; 3(4):266-74. PubMed ID: 20972373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.
    Sayed-Ahmed MM; Hafez MM; Aldelemy ML; Aleisa AM; Al-Rejaie SS; Al-Hosaini KA; Al-Harbi NO; Al-Harbi MM; Al-Shabanah OA
    Oxid Med Cell Longev; 2012; 2012():696704. PubMed ID: 23213347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.
    Sayed-Ahmed MM; Aldelemy ML; Al-Shabanah OA; Hafez MM; Al-Hosaini KA; Al-Harbi NO; Al-Sharary SD; Al-Harbi MM
    Cardiovasc Toxicol; 2014 Sep; 14(3):232-42. PubMed ID: 24469765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats.
    Sener G; Sehirli O; Yegen BC; Cetinel S; Gedik N; Sakarcan A
    J Pineal Res; 2004 Aug; 37(1):17-25. PubMed ID: 15230864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol improves ifosfamide-induced Fanconi syndrome in rats.
    Sehirli O; Sakarcan A; Velioğlu-Oğünç A; Cetinel S; Gedik N; Yeğen BC; Sener G
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):33-41. PubMed ID: 17481685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of cyclophosphamide-induced acute renal metabolic damage in carnitine-depleted rat model.
    Sayed-Ahmed MM
    Clin Exp Nephrol; 2010 Oct; 14(5):418-26. PubMed ID: 20652348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus.
    Al-Majed AA; Sayed-Ahmed MM; Al-Omar FA; Al-Yahya AA; Aleisa AM; Al-Shabanah OA
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):725-33. PubMed ID: 16895547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine attenuates fanconi syndrome induced by ifosfamide without compromising its antitumor activity.
    Badary OA
    Oncol Res; 1998; 10(7):355-60. PubMed ID: 10063969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
    Sayed-Ahmed MM; Eissa MA; Kenawy SA; Mostafa N; Calvani M; Osman AM
    Chemotherapy; 2004 Oct; 50(4):162-70. PubMed ID: 15347908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats.
    Nissim I; Weinberg JM
    Kidney Int; 1996 Mar; 49(3):684-95. PubMed ID: 8648909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine deficiency aggravates cyclophosphamide-induced cardiotoxicity in rats.
    Fatani AG; Darweesh AQ; Rizwan L; Aleisa AM; Al-Shabanah OA; Sayed-Ahmed MM
    Chemotherapy; 2010; 56(1):71-81. PubMed ID: 20299794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model.
    Al-Majed AA; Sayed-Ahmed MM; Al-Yahya AA; Aleisa AM; Al-Rejaie SS; Al-Shabanah OA
    Pharmacol Res; 2006 Mar; 53(3):278-86. PubMed ID: 16436331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efforts to establish an animal model of Fanconi syndrome after ifosfamide administration to rats.
    Appenroth D; Werner T; Lupp A; Patzer L; Misselwitz J; Fleck C
    J Appl Toxicol; 2007; 27(4):327-36. PubMed ID: 17265418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of L-carnitine on myoglobinuric acute renal failure in rats.
    Aydogdu N; Atmaca G; Yalcin O; Taskiran R; Tastekin E; Kaymak K
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):119-24. PubMed ID: 16445710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Histidinol attenuates Fanconi syndrome induced by ifosfamide in rats.
    Badary OA
    Exp Nephrol; 1999; 7(4):323-7. PubMed ID: 10450020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine deficiency aggravates carboplatin nephropathy through deterioration of energy status, oxidant/anti-oxidant balance, and inflammatory endocoids.
    Arafa HM
    Toxicology; 2008 Dec; 254(1-2):51-60. PubMed ID: 18852009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats.
    Sayed-Ahmed MM; Nagi MN
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):399-405. PubMed ID: 17439407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.